Selective activation of sphingosine 1-phosphate receptors 1 and 3 promotes local microvascular network growth

Tissue Engineering - Part A

Volumn 17, Issue 5-6, 2011, Pages 617-629

  Sefcik, Lauren S ^a   Petrie Aronin, Caren E ^b   Awojoodu, Anthony O ^c   Shin, Soo J ^c   Mac Gabhann, Feilim ^d   MacDonald, Timothy L ^e   Wamhoff, Brian R ^e,f   Lynch, Kevin R ^f   Peirce, Shayn M ^c   Botchwey, Edward A ^c,e,f  

^a LAFAYETTE COLLEGE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c University of Virginia   (United States)

^d Johns Hopkins University   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADABLE POLYMERS; CHEMICAL ACTIVATION; PLANTS (BOTANY); TISSUE ENGINEERING;

FUNCTIONAL NETWORK; LENGTH DENSITY; MICROVASCULAR; MICROVASCULAR GROWTH; MICROVASCULAR NETWORK; POLY(D , L-LACTIC-CO-GLYCOLIC ACID); POTENT ACTIVATORS; SELECTIVE ACTIVATION; SPHINGOSINE 1 PHOSPHATES; STIMULATED BRANCHING; SUSTAINED RELEASE; TISSUE ENGINEERING APPLICATIONS; VASCULAR BRANCHING; VASCULAR NETWORK; WINDOW CHAMBERS;

BLOOD VESSELS;

ACTIN; DRUG DERIVATIVE; FINGOLIMOD; PROPANEDIOL DERIVATIVE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

ANGIOGENESIS; ANIMAL; ANIMAL MODEL; ARTICLE; C57BL MOUSE; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG ANTAGONISM; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; MALE; METABOLISM; MICROVASCULATURE; MOUSE; MUSCLE; SIGNAL TRANSDUCTION;

ACTINS; ANIMALS; DELAYED-ACTION PREPARATIONS; MALE; MICE; MICE, INBRED C57BL; MICROVESSELS; MODELS, ANIMAL; MUSCLES; NEOVASCULARIZATION, PHYSIOLOGIC; PROPYLENE GLYCOLS; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 79952163918     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0404     Document Type: Article

References (43)

1. Jain, R. K. Molecular regulation of vessel maturation. Nat Med 9, 685, 2003.
2. Price, R. J., Owens, G. K., and Skalak, T. C. Immunohistochemical identification of arteriolar development using markers of smooth muscle differentiation. Evidence that capillary arterialization proceeds from terminal arterioles. Circ Res 75, 520, 1994.
3. Benest, A. V., Stone, O. A., Miller, W. H., Glover, C. P., Uney, J. B., Baker, A. H., Harper, S. J., and Bates, D. O. Arteriolar genesis and angiogenesis induced by endothelial nitric oxide synthase overexpression results in a mature vasculature. Arterioscler Thromb Vasc Biol 28, 1462, 2008.
4. Van Royen, N., Piek, J. J., Schaper, W., Bode, C., and Buschmann, I. Arteriogenesis: mechanisms and modulation of collateral artery development. J Nucl Cardiol 8, 687, 2001.
5. Peirce, S. M., Price, R. J., and Skalak, T. C. Spatial and temporal control of angiogenesis and arterialization using focal applications of VEGF164 and Ang-1. Am J Physiol Heart Circ Physiol 286, H918, 2004.
6. Kimura, T., Sato, K., Malchinkhuu, E., Tomura, H., Tamama, K., Kuwabara, A., Murakami, M., and Okajima, F. Highdensity lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors. Arterioscler Thromb Vasc Biol 23, 1283, 2003.
7. Lee, H., Goetzl, E. J., and An, S. Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. Am J Physiol Cell Physiol 278, C612, 2000.
8. Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C. X., Hobson, J. P., Rosenfeldt, H. M., Nava, V. E., Chae, S. S., Lee, M. J., Liu, C. H., Hla, T., Spiegel, S., and Proia, R. L. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 106, 951, 2000.
9. Paik, J. H., Skoura, A., Chae, S. S., Cowan, A. E., Han, D. K., Proia, R. L., and Hla, T. Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization. Genes Dev 18, 2392, 2004.
10. Kluk, M. J., and Hla, T. Role of the sphingosine 1-phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration. Circ Res 89, 496, 2001.
11. Lockman, K., Hinson, J. S., Medlin, M. D., Morris, D., Taylor, J. M., and Mack, C. P. Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors. J Biol Chem 279, 42422, 2004.
12. Taha, T. A., Argraves, K. M., and Obeid, L. M. Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy. Biochim Biophys Acta 1682, 48, 2004.
13. Goetzl, E. J., and Rosen, H. Regulation of immunity by lysosphingolipids and their G protein-coupled receptors. J Clin Invest 114, 1531, 2004.
14. Rosen, H., and Liao, J. Sphingosine 1-phosphate pathway therapeutics: a lipid ligand-receptor paradigm. Curr Opin Chem Biol 7, 461, 2003.
15. Sefcik, L. S., Petrie Aronin, C. E., Wieghaus, K. A., and Botchwey, E. A. Sustained release of sphingosine 1-phosphate for therapeutic arteriogenesis and bone tissue engineering. Biomaterials 29, 2869, 2008.
16. Nickerson, M. M., Song, J., Shuptrine, C. W., Wieghaus, K. A., Botchwey, E. A., and Price, R. J. Influence of poly (D, L-lacticco-glycolic acid) microsphere degradation on arteriolar remodeling in the mouse dorsal skinfold window chamber. J Biomed Mater Res A 91, 317, 2009.
17. Murray, J. Angiogenesis protocols. Totowa, NJ: Humana Press, 2001.
18. Bailey, A. M., O'Neill, T. J., 4th, Morris, C. E., and Peirce, S. M. Arteriolar remodeling following ischemic injury extends from capillary to large arteriole in the microcirculation. Microcirculation 15, 389, 2008.
19. MacGabhann, F., and Peirce, S. M. Collateral capillary arterialization following arteriolar ligation in murine skeletal muscle. Microcirculation 17, 333, 2010.
20. Zhu, R., Snyder, A. H., Kharel, Y., Schaffter, L., Sun, Q., Kennedy, P. C., Lynch, K. R., and Macdonald, T. L. Asymmetric synthesis of conformationally constrained fingolimod analogues-discovery of an orally active sphingosine 1-phosphate receptor type-1 agonist and receptor type-3 antagonist. J Med Chem 50, 6428, 2007.
21. Erdo, F., and Buschmann, I. R. Arteriogenesis: a new strategy of therapeutic intervention in chronic arterial disorders. Cellular mechanism and experimental models. Orv Hetil 148, 633, 2007.
22. Lekas, M., Lekas, P., Latter, D. A., Kutryk, M. B., and Stewart, D. J. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation? Curr Opin Cardiol 21, 376, 2006.
23. Sefcik, L. S., Petrie Aronin, C. E., and Botchwey, E. A. Engineering vascularized tissues using natural and synthetic small molecules. Organogenesis 4, 215, 2008.
24. Owens, G. K., Kumar, M. S., and Wamhoff, B. R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84, 767, 2004.
25. Wamhoff, B. R., Lynch, K. R., Macdonald, T. L., and Owens, G. K. Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 28, 1454, 2008.
26. Sanchez, T., Estrada-Hernandez, T., Paik, J. H., Wu, M. T., Venkataraman, K., Brinkmann, V., Claffey, K., and Hla, T. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J Biol Chem 278, 47281, 2003.
27. Thurston, G., Wang, Q., Baffert, F., Rudge, J., Papadopoulos, N., Jean-Guillaume, D., Wiegand, S., Yancopoulos, G. D., and McDonald, D. M. Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period. Development 132, 3317, 2005.
28. Schmid, G., Guba, M., Ischenko, I., Papyan, A., Joka, M., Schrepfer, S., Bruns, C. J., Jauch, K. W., Heeschen, C., and Graeb, C. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1. J Cell Biochem 101, 259, 2007.
29. van Meeteren, L. A., Brinkmann, V., Saulnier-Blache, J. S., Lynch, K. R., and Moolenaar, W. H. Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D. Cancer Lett 266, 203, 2008.
30. LaMontagne, K., Littlewood-Evans, A., Schnell, C., O'Reilly, T., Wyder, L., Sanchez, T., Probst, B., Butler, J., Wood, A., Liau, G., Billy, E., Theuer, A., Hla, T., and Wood, J. Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization. Cancer Res 66, 221, 2006.
31. Liu, C. H., Thangada, S., Lee, M. J., Van Brocklyn, J. R., Spiegel, S., and Hla, T. Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1. Mol Biol Cell 10, 1179, 1999.
32. Oo, M. L., Thangada, S., Wu, M. T., Liu, C. H., Macdonald, T. L., Lynch, K. R., Lin, C. Y., and Hla, T. Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. J Biol Chem 282, 9082, 2007.
33. Keul, P., Tolle, M., Lucke, S., von Wnuck Lipinski, K., Heusch, G., Schuchardt, M., van der Giet, M., and Levkau, B. The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 27, 607, 2007.
34. Okamoto, H., Takuwa, N., Yokomizo, T., Sugimoto, N., Sakurada, S., Shigematsu, H., and Takuwa, Y. Inhibitory regulation of Rac activation, membrane ruffling, and cell migration bythe Gprotein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. Mol Cell Biol 20, 9247, 2000.
35. Coussin, F., Scott, R. H., Wise, A., and Nixon, G. F. Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles: differential role in vasoconstriction. Circ Res 91, 151, 2002.
36. Mazurais, D., Robert, P., Gout, B., Berrebi-Bertrand, I., Laville, M. P., and Calmels, T. Cell type-specific localization of human cardiac S1P receptors. J Histochem Cytochem 50, 661, 2002.
37. Walter, D. H., Rochwalsky, U., Reinhold, J., Seeger, F., Aicher, A., Urbich, C., Spyridopoulos, I., Chun, J., Brinkmann, V., Keul, P., Levkau, B., Zeiher, A. M., Dimmeler, S., and Haendeler, J. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor. Arterioscler Thromb Vasc Biol 27, 275, 2007.
38. Petrie Aronin, C. E., Sefcik, L. S., Tholpady, S. S., Tholpady, A., Sadik, K. W., Macdonald, T. L., Peirce, S. M., Wamhoff, B. R., Lynch, K. R., Ogle, R. C., and Botchwey, E. A. FTY720 promotes local microvascular network formation and regeneration of cranial bone defects. Tissue Eng A 16, 1801, 2010.
39. Saba, J. D., and Hla, T. Point-counterpoint of sphingosine 1-phosphate metabolism. Circ Res 94, 724, 2004.
40. Butler, J., Lana, D., Round, O., and LaMontagne, K. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells. Prostaglandins Other Lipid Mediators 73, 29, 2004.
41. Osada, M., Yatomi, Y., Ohmori, T., Ikeda, H., and Ozaki, Y. Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist. Biochem Biophys Res Commun 299, 483, 2002.
42. Kawanabe, T., Kawakami, T., Yatomi, Y., Shimada, S., and Soma, Y. Sphingosine 1-phosphate accelerates wound healing in diabetic mice. Journal of dermatological science 48, 53, 2007.
43. Inoki, I., Takuwa, N., Sugimoto, N., Yoshioka, K., Takata, S., Kaneko, S., and Takuwa, Y. Negative regulation of endothelial morphogenesis and angiogenesis by S1P2 receptor. Biochem Biophys Res Commun 346, 293, 2006.